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Abstract Several lines of GH-overexpressing fish
have been produced and characterized concerning
organ integrity, growth, fertility and health but few
and contradictory data are available on IGF-I that
mediates most effects of GH. Furthermore, nothing is
known on IGF-II. Thus, the expression of both IGFs
in liver and various extrahepatic sites of adult
transgenic (GH-overexpressing) tilapia and age-
matched wild-type fish was determined by real-time
PCR. Both IGF-I and IGF-II mRNA were found in all
organs investigated and were increased in gills,
kidney, intestine, heart, testes, skeletal muscle and
brain of the transgenics (IGF-I: 1.4–4-fold; IGF-II:
1.7–4.2-fold). Except for liver, brain and testis the
increase in IGF-I mRNA was higher than that in IGF-
II mRNA. In pituitary, no significant change in IGF-I
or IGF-II mRNA was detected. In spleen, however,
IGF-I and IGF-II mRNA were both decreased in the
transgenics, IGF-I mRNA even by the 19-fold. In
agreement, in situ hybridisation revealed a largely
reduced number of IGF-I mRNA-containing leuko-
cytes and macrophages when compared to wild-type.
These observations may contribute to better under-
standing the reported impaired health of GH-trans-
genic fish. Growth enhancement of the transgenics
may be due to the increased expression of both IGF-I
and IGF-II in extrahepatic sites. It is also reasonable
that the markedly enhanced expression of liver IGF-II
mRNA that may mimick an early developmental
stage is a further reason for increased growth.
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Introduction
The insulin-like growth factors (IGF-I, IGF-II)
belong to a family of hormones with structural
similarities to insulin. Whereas IGF-I is known as
potent mitogenic hormone that induces growth and
differentiation in a variety of target organs (Reinecke
and Collet 1998), the role of IGF-II is still enigmatic
(Reinecke et al. 2005). Most studies on the IGF-
system in non-mammalian vertebrates deal with
bony fish which are of special commercial value.
Thus, scientific results on growth regulation in fishes
E. Eppler  G. Berishvili  P. Mazel
Research Group Neuro-Endocrine-Immune Interactions,
Institute of Anatomy, University of Zu¨rich,
Winterthurerstr. 190, CH-8057 Zu¨rich, Switzerland
A. Caelers  M. Reinecke (&)
Division of Neuroendocrinology, Institute of Anatomy,
University of Zu¨rich, Winterthurerstr. 190, CH-8057
Zu¨rich, Switzerland
e-mail: reinecke@anatom.uzh.ch
G. Hwang  N. Maclean
Division of Cell Science, School of Biological Sciences,
University of Southampton, Hampshire SO16 7PX, UK
123
Transgenic Res (2010) 19:231–240
DOI 10.1007/s11248-009-9314-8
are not only relevant for basic research but also for
aquaculture.
In mammals, IGF-I is mainly produced in liver, the
principal source of endocrine IGF-I, whereby the
primary stimulus for synthesis and release of liver
IGF-I is growth hormone (GH) from the anterior
pituitary (Reinecke and Collet 1998; Reinecke et al.
2005). In bony fish, the major site of IGF-I gene
expression also is liver (Duan 1998; Reinecke et al.
2005; Wood et al. 2005) and GH injections promoted
liver IGF-I mRNA expression and increased IGF-I
serum levels in salmonids, seabream and tilapia
(Reinecke et al. 2005). In vitro, GH also stimulated
IGF-I expression in primary hepatocyte cultures of
salmonids (Shamblott et al. 1995; Pierce et al. 2005),
tilapia (Schmid et al. 2000, 2003), and seabream
(Leung et al. 2008). Furthermore, there is evidence
for extrahepatic IGF-I production in fishes (for
references see: Caelers et al. 2004; Eppler et al.
2007a), especially during development (Berishvili
et al. 2006a, b; Patruno et al. 2008) and for partial
regulation by GH in extrahepatic sites (Tse et al.
2002; Vong et al. 2003; Biga et al. 2004; Eppler et al.
2007a).
In several bony fish IGF-II gene expression was
detected in all IGF-I mRNA-expressing organs
(Shamblott et al. 1995; Duguay et al. 1996; Collet
et al. 1997; Loffing-Cueni et al. 1999; Schmid et al.
1999; Caelers et al. 2004; Moriyama et al. 2008)
which raises the question whether or not the expres-
sions of IGF-I and IGF-II may be simultaneously
regulated in different organs. So far, only few and
inconsistent data on GH action towards IGF-II gene
expression have been obtained in seabream, rainbow
trout, Japanese eel and carp (Shamblott et al. 1995;
Duguay et al. 1996; Perrot and Funkenstein 1999; Tse
et al. 2002; Vong et al. 2003; Moriyama et al. 2008)
and nothing is known for transgenic fish carrying
exogenous GH gene constructs which provide valu-
able tools for the investigation of GH action on IGF-I
and IGF-II expression. Furthermore, although inves-
tigations on transgenic fish have mainly dealt with
growth parameters, fertility, body and organ integrity
(Rahman et al. 1998; Maclean et al. 2002; Sundstro¨m
et al. 2004), only few observations have been made
on the immune system. Taking into account the
relevance of farmed fish as nutrition factor, suscep-
tibility to infection is important, especially since the
enormous enlargement of aquaculture goes along
with fish rearing at high density leading to increased
infections.
There is evidence for neuroendocrine-immune
interactions in fish (Segner et al. 2006; Bowden
2008) but interactions of the GH/IGF-I system and
the immune system in fishes are not understood at all.
So far, the GH receptor has been detected on
hematopoetic cells and in head kidney of gilthead
seabream (Calduch-Giner and Pe´rez-Sa´nchez 1999;
Sitja`-Bobadilla et al. 2008), and tilapia (Shved et al.
2009), IGF-I gene or peptide expression in lymphoid
tissues of several fish species including tilapia (for
references see: Shved et al. 2009), and the IGF-I
receptor on immune cells and in head kidney of
gilthead seabream (Funkenstein et al. 1997; Sitja`-
Bobadilla et al. 2008). Expression of both IGF-I and
IGF-II genes was described in tilapia spleen (Caelers
et al. 2004; Shved et al. 2009) and gilthead seabream
and tilapia head kidney (Sitja`-Bobadilla et al. 2008;
Shved et al. 2009).
Thus, only few and contradictory results are
available on the expression of IGF-I in transgenic
fish, and nothing is known on IGF-II. Thus, the aim
of the present study was to investigate the long-term
regulation of IGF-I and IGF-II by GH in teleost fish.
As experimental model we have chosen a transgenic
(GH-overexpressing) tilapia (Oreochromis niloticus).
Materials and methods
Production, maintenance, and discrimination
of transgenic and wild-type fish
As experimental model we used transgenic,
GH-overexpressing Oreochromis niloticus previously
produced from crosses between a wild type female
Oreochromis niloticus and a G1 transgenic male.
This line of growth-enhanced tilapia (C86) carries a
single copy of a chinook salmon (Oncorhynchus
tschawytscha) GH gene spliced to an ocean pout
(Macrozoarces americanus) antifreeze promoter (OP-
AFPcsGH) co-ligated with a carp beta actin/lacZ
reporter gene construct, integrated into the tilapia
genome (Rahman et al. 1998). Tilapia were bred in
tanks at 24–25C under a 13/11 h light/dark cycle
and fed with trout pellets 3 times a day to satiation as
described previously (Rahman et al. 1998). In order
to discriminate the transgenic or non-transgenic state
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of the individuals, PCR was carried out on DNA from
fin clips. An approximately 3 9 2 mm clip was taken
from the caudal fin of each individual investigated
and immediately frozen in liquid nitrogen. Prior to fin
clipping, fish were tagged with transponders (Fish
Culture Research Institute, FCRI growth trial) to
allow identification of each fish after PCR analysis.
Isolation and purification of DNA and subsequent
PCR and Southern Blotting were performed as
previously described (Rahman et al. 1998) by using
primers to detect novel junction fragments between
the exogenous GH gene and the reporter gene.
Tissue sampling
17 months old individuals of the C86 strain of
Oreochromis niloticus (n = 10) and non-transgenic
siblings (n = 10) were used. Pituitaries and small
tissue samples of liver, intestine, heart, brain, gills,
kidney, spleen, skeletal muscle and testis were
rapidly excised and, for RNA preservation, immedi-
ately transferred into 1.5 ml of RNAlaterTM (Ambi-
on, Austin, TX). The samples were kept overnight at
4C and later stored at -20C until RNA isolation.
For in situ hybridisation, specimens were fixed by
immersion in Bouin’s solution without acetic acid for
4 h at room temperature, dehydrated in ascending
series of ethanol and routinely embedded in paraplast
(58C).
Real-time PCR
Tilapia IGF-I, IGF-II and ß-actin specific primers and
probes were designed as already described (Caelers
et al. 2004) based on the sequences of Oreochromis
mossambicus IGF-I (Reinecke et al. 1997), IGF-II
(Chen et al. 1998), and O. niloticus ß-actin (Hwang
et al. 2003). Total RNA was extracted using
TRIzolReagent (Invitrogen, Belgium) and treated
with 1 U of RQ1 RNAse-free DNase (Catalys,
Switzerland). Samples were subjected individually
to real-time PCR as already described (Caelers et al.
2004). In brief, triplicates of 10 ng of total RNA were
subjected in parallel to real-time PCR using one-step
RT-PCR Mastermix (Applied Biosystems, Rotkreuz,
Switzerland). Each 25 ll RT-PCR mixture contained
12.5 ll 29 Master Mix (AmpliTaqGoldDNA Poly-
merase, dNTPs with dUTP, Passive Reference 1 and
optimized buffer components), 0.625 ll 409 RT
enzyme mix (Multi-ScribeTMReverse Transcriptase
and RNase inhibitor), 300 nM of each primer,
150 nM of fluorogenic TaqMan probe and 1 ll of
10 ng/ll diluted RNA. A reverse transcription step of
30 min at 48C and a denaturation step of 10 min at
95C were followed by 40 cycles of 15 s at 95C and
1 min at 60C. Reverse transcription and amplifica-
tion were carried out in a single tube using an ABI
PRISMTM 7700 Sequence Detection System (Applied
Biosystems).
Generation of probes for in situ hybridisation
Probes for in situ hybridisation were prepared as
already described (Schmid et al. 1999; Berishvili et al.
2006a, b). In brief, total RNA from tilapia liver was
extracted with the Ultraspec Extraction Kit (ams,
Lugano, Switzerland). For cDNA synthesis 5 lg RNA
were annealed with 1 lM of a poly(dT) primer (50-
CCTGAATTCTAGAGCTCAT(dT17)-30) for 3 min
at 70C. The RNA/primer mix was incubated for 1 h
at 37C with 15 mM dNTPs and 10 U AMV-RTase
(Pharmacia, Switzerland) in 19 reaction buffer. One
microliter cDNA was incubated with 1 lM of sense
and antisense primers corresponding to the B- and
E- domain, 200 lM dNTPs, and 1 U Taq-polymerase
(Pharmacia) in 19 incubation buffer. The amplifica-
tion program was optimised for a Stratagene Robo-
Cycler Gradient 40: 1 cycle 10 min at 94C, 1 min at
59C, 2 min at 72C; 30 cycles 1 min at 94C, 1 min
at 59C and 2 min at 72C followed by final extension
of 5 min at 72C. PCR fragments were separated on a
2% agarose gel and eluted by the Gel Extraction Kit
QIAquick (Qiagen, Switzerland). Subsequently, the
PCR products were cloned in a pCR-Script SK(?)
cloning vector using a kit (Stratagene, Heidelberg,
Germany). Plasmids containing the gene sequence
fragments were sequenced (Microsynth, Switzerland)
and the sequences compared to database. The plas-
mids containing the specific inserts of IGF-I (207 bp)
were used as templates for the synthesis of digoxi-
genin (DIG)-labelled RNA probes. Linearisation
was performed with EcoRI for T3- and NotI for
T7-polymerase-driven transcription. One lg of line-
arised plasmid was transcribed in vitro in the presence
of DIG-UTP from T3 and T7 promotors to obtain
antisense and sense probes. Integrity of probes and
efficiency of labelling were confirmed by dot blot and
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gel electrophoresis including blotting and incubation
with antibody.
In situ hybridisation
Four lm sections on Super Frost Plus slides (Menzel-
Gla¨ser, Germany) were dewaxed, rehydrated in
descending series of ethanol, and postfixed with 4%
PFA and 0.1% GA in 19 PBS. The following steps
were carried out with DEPC-treated solutions in a
humidified chamber: sections were digested with
0.02% proteinase K in 20 mM Tris–HCl/pH 7.4,
2 mM CaCl2 for 10 min at 37C and treated with
1.5% triethanolamine and 0.25% acid anhydride for
10 min at room temperature. Slides were incubated
with 100 ll prehybridisation solution per section for
3 h at 54C. Hybridisation was carried out overnight
at 54C with 50 ll of hybridisation buffer containing
200 ng of sense or antisense probes previously
denaturated for 5 min at 85C. Slides were washed
for 15 min at room temperature in 29 SSC, and for
30 min at 54C at descending concentrations of SSC.
Sections were incubated with alkaline phosphatase-
coupled anti-DIG antibody diluted 1:4000 in 1%
blocking reagent in buffer P1 for 1 h at room
temperature in the dark. After washing, sections were
treated with buffer P3, 5 mM levamisole and NBT/
BCIP stock solution. Colour development was per-
formed overnight at room temperature and stopped by
rinse in tap water for 15 min. Sections were mounted
with glycergel. Microscopy and photography were
performed with a Zeiss Axioscope using the Axiovi-
sion 3.1 software (Zeiss, Zu¨rich, Switzerland). Spec-
ificity of the probes has been previously demonstrated
for tilapia male and female gonads (Schmid et al.
1999; Berishvili et al. 2006a), liver (Schmid et al.
1999), brain (Shved et al. 2007), pituitary (Eppler
et al. 2007b), and head kidney (Shved et al. 2009).
Statistical analysis
All experimental data for IGF-I and IGF-II are
expressed as n-fold changes of gene expression in the
GH-transgenic fish relative to the wild type control
level set as 1. The comparative threshold cycle
(DDCT) method was used to calculate relative gene
expression ratios as previously described (Shved
et al. 2007, 2009). Efficiency tests for b-actin, IGF-
I and IGF-II assays (Caelers et al. 2004) permitted the
accurate use of the DDCT method. Data were
normalized to b-actin as reference gene. Stability of
b-actin gene expression between transgenic and
control fish was assured. Statistical significance was
calculated using Mann–Whitney rank sum test, with
an exact P value. Statistical analyses were performed
with GraphPad Prism 4.
Results
IGF-I and IGF-II mRNA expression in liver
IGF-I mRNA was slightly (1.391-fold, P \ 0.0028)
elevated in transgenics as compared to the control fish
whereas IGF-II mRNA expression was pronouncedly
elevated (4.232-fold, P \ 0.0075) (Table 1).
IGF-I and IGF-II mRNA expression
in skeletal muscle
IGF-I mRNA was approximately doubled (1.996-fold,
P \ 0.0075) in transgenic skeletal muscle (Table 1) as
compared to the control fish whereas IGF-II mRNA
expression was less increased (1.655-fold, P \ 0.015).
IGF-I and IGF-II mRNA expression
in gills and kidney
In gills (Table 1), both IGF-I and IGF-II mRNA were
approximately doubled (IGF-I: 2.050-fold, P\0.0066;
IGF-II: 2.022-fold, P\0.0075) in the GH-transgenics as
compared to the control fish. In kidney (Table 1), IGF-I
gene expression (2.283-fold, P\0.0043) was more
pronouncedly enhanced than IGF-II mRNA expression
(1.829-fold, P\0.0423).
IGF-I and IGF-II mRNA expression in intestine
In intestine (Table 1), IGF-I gene expression was
strongly elevated (4.019-fold, P \ 0.008) in trans-
genics, whereas elevation of IGF-II mRNA was less
pronounced but still twice (2.186-fold, P \ 0.025) of
that found in the control fish.
IGF-I and IGF-II mRNA expression in heart
IGF-I mRNA was markedly (2.283-fold, P \ 0.0062)
increased in the transgenics as compared to the
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controls while IGF-II mRNA expression was only
slightly elevated (1.462-fold) in transgenics as com-
pared to the control (Table 1).
IGF-I and IGF-II mRNA expression in testis
Both IGF-I and IGF-II mRNAs were strongly
enhanced (IGF-I: 2.287-fold, P \ 0.016; IGF-II:
2.455-fold, P \ 0.011) in the GH-transgenics as
compared to the control fish (Table 1).
IGF-I and IGF-II mRNA expression in spleen
In spleen, both IGF-I and IGF-II mRNAs were lower
in the GH-transgenics as compared to the control fish
(Table 1) whereby in the transgenic tilapia gene
suppression was much more pronounced for IGF-I
which was lowered by -18.804-fold (P = 0.0013)
whereas IGF-II gene was suppressed by -2.018-fold.
The suppressed IGF-I gene expression in spleen
was verified by in situ hybridisation (Fig. 1) where a
similarly reduced IGF-I gene expression in leuko-
cytes and macrophages was observed in the trans-
genics (Fig. 1b) when compared to the control fish
(Fig. 1a). Moreover, in the transgenics, a larger area
of the melanomacrophage centres was observed
whereby the melanomacrophages were strongly
reduced in number (Fig. 1b).
IGF-I and IGF-II mRNA expression
in brain and pituitary
IGF-I mRNA was slightly (1.353-fold, P \ 0.0001)
elevated in brain of the transgenics as compared to
Table 1 Ratio (±standard deviation, SD) of IGF-I and IGF-II mRNA levels of transgenic GH-overexpressing tilapia organs as
compared to wild-type (set as 1) gene expression levels
Organ IGF-I IGF-II sGHa
Ratio SD P-value Ratio SD P-value pg/lg SD
Liver 1.391 0.516 \0.0028 4.232 1.921 \0.0075 8.3 2.5
Muscle 1.996 0.817 \0.0075 1.655 0.833 \0.015 2.6 1.4
Gills 2.050 0.869 \0.0066 2.022 0.719 \0.0075 4.1 2.0
Kidney 2.283 0.426 \0.0043 1.829 0.741 \0.0423 0.2 0.08
Intestine 4.019 1.426 \0.008 2.186 0.997 \0.025 0.7 0.63
Heart 2.283 0.809 \0.0062 1.462 0.697 NS 1.9 0.8
Testis 2.287 1.251 \0.016 2.455 1.096 \0.011 2.0 1.7
Spleen -18.804 3.033 =0.0013 -2.018 0.656 NS 0.6 0.52
Brain 1.353 0.449 \0.0001 2.038 0.379 \0.0025 1.4 0.5
Pituitary 1.192 0.180 NS 1.200 0.378 NS ND ND
NS not significant, ND not detected
a Data are presented together with absolute amounts (pg/lg total RNA) of the exogenous salmon (s)GH mRNA as previously
published (Caelers et al. 2005)
Fig. 1 In situ hybridisation
of IGF-I gene expression in
spleen and melanomacro-
phage centres (MMC) of
a control and b transgenic
fish. Enlarged MMC occur
in the transgenic fish. In
wild-type tilapia (a) much
more leukocytes express
IGF-I mRNA (arrows) than
in the transgenic tilapia (b).
Bar: 240 lm
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the control fish. IGF-II mRNA expression was
pronouncedly elevated (2.038-fold, P \ 0.0025) in
transgenics as compared to the control fish brain
(Table 1). No significant effect (IGF-I: 1.192-fold;
IGF-II: 1.200-fold) was observed in pituitary of the
transgenic fish when compared to the wild-type fish
(Table 1).
Discussion
In the present study, both IGF-I and IGF-II mRNA
levels were increased in liver of the transgenics. For
IGF-I this is consistent with previous reports in fish
including our own transgenic tilapia (Eppler et al.
2007a) that GH treatment stimulates liver IGF-I gene
expression. For IGF-II expression, no GH effect was
found in gilthead seabream (Duguay et al. 1996) but,
in accordance with our results, GH increased IGF-II
mRNA levels in rainbow trout, common carp and
Japanese eel (Shamblott et al. 1995; Vong et al. 2003;
Moriyama et al. 2008), and in rainbow trout and
redbanded seabream, similar to our findings in tilapia,
more pronouncedly than IGF-I mRNA (Gahr et al.
2008; Ponce et al. 2008).
IGF-II mRNA in muscle was similarly increased in
the GH-overexpressing fish as found previously for
IGF-I mRNA (Eppler et al. 2007a) which suggests
that expression of both IGFs in muscle is under
control by GH. For IGF-I, this agrees with the work
of Kajimura et al. (2001) who observed an increase in
tilapia muscle IGF-I mRNA after GH injection and
with results in transgenic GH-overexpressing coho
salmon (Raven et al. 2008). Recently, it has been
shown in muscle cells of rainbow trout that IGF-II
exerts mitogenic and metabolic effects equivalent to
those of IGF-I (Codina et al. 2008). Thus, the
markedly enhanced growth of the transgenics (Rah-
man et al. 1998) probably is due to raised local
expression of both, IGF-I and IGF-II in muscle.
In tilapia gills which possess the GH receptor
(Fryer 1979) and express IGF-I at higher levels than
IGF-II (Caelers et al. 2004), both IGFs were more
intensely expressed in the transgenics. Together with
similar results in GH-injected common carp (Vong
et al. 2003) this strongly indicates that both IGFs in
gills are under control by GH which is of particular
relevance since GH and IGF-I are believed to play a
major role in osmoregulation (e.g., Shepherd et al.
2005; Cao et al. 2009). Also in wild type tilapia
kidney, IGF-I was expressed at a higher level than
IGF-II (Caelers et al. 2004). In the GH-overexpress-
ing tilapia, both IGF-I and IGF-II expressions were
pronouncedly elevated although the GH-transgene
was expressed at a relatively low level. This gives
support to the hypothesis that the presence of the
transgene is more important than its absolute amount
(Herna´ndez et al. 1997; Caelers et al. 2005). Similar
to elevated IGF-I and IGF-II mRNA levels in
common carp upon GH administration (Vong et al.
2003), in the present study in intestine of transgenic
tilapia a four and twofold increase, respectively, in
IGF-I and IGF-II expressions was found suggesting a
role for both in the proposed enhanced food uptake
and conversion of GH-transgenic fish (Devlin et al.
1995).
IGF-I and IGF-II mRNA expression were found in
salmonid and tilapia testes and ovary (e. g. Shamblott
and Chen 1993; Duguay et al. 1994; Schmid et al.
1999; Perrot et al. 2000; Biga et al. 2004) and
absolute gene expression levels of both IGFs in wild
type tilapia testis were second after liver (Caelers
et al. 2004). In the present study, increased expres-
sions of both IGFs were found in testis of the
transgenic tilapia along with a considerable expres-
sion of the exogenous transgene (Caelers et al. 2005).
Thus, our study suggests that both IGF-I and IGF-II
act as local mediators of GH in fish testis, an
assumption compatible with results in rainbow trout
(Perrot and Funkenstein 1999) where GH and pitu-
itary extracts induced eightfold and two to threefold
increases in IGF-I and IGF-II mRNA levels, respec-
tively, and with the presence of GH receptors in fish
testis (Le Gac et al. 1992).
Surprisingly in spleen, IGF-I and IGF-II mRNA
were in contrast to the other organs expressed at
lower levels in GH-transgenic than control fish
although GH is generally assumed to exert stimula-
tory effects on the immune system. For instance, GH
increased unspecific leukocyte activity in rainbow
trout, tilapia and gilthead seabream in vitro and in
vivo (Kajita et al. 1992; Sakai et al. 1996, 1997;
Calduch-Giner et al. 1997; Yada et al. 2002) and
assisted in vitro the recovery of cortisol-treated
rainbow trout leukocytes (Yada et al. 2004). Vice
versa, hypophysectomy decreased superoxide anion
production of tilapia head kidney leukocytes (Yada
et al. 2002). In our study, life-long stimulation with
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GH enlarged the melanomacrophage centres which
are considered as primitive analogues of lymphnodes
in higher teleosts (Agius and Roberts 2003). In the
transgenics, they contained very few melanomacro-
phages which indicates a modified cell composition
in the transgenic state. High mortalities of GH-
transgenic coho salmon have been reported (Devlin
et al. 1995) that may be caused by impaired immune
function (Jhingan et al. 2003). For instance, in GH-
transgenic amago salmon, lowered serum lysozyme
activity was detected (Mori et al. 2007) in contrast to
elevated lysozyme activity in GH-treated rainbow
trout and channel catfish (Yada et al. 2001; Peterson
et al. 2007) suggesting a modification of the innate
immune system by the GH-transgenic state (Mori
et al. 2007). The largely reduced expression of IGF-I
mRNA in leukocytes and macrophages in the present
study together with lowered IGF-I serum levels in our
transgenics (Eppler et al. 2007a) may lead to a local
IGF-I deficiency which may contribute to explain the
reported impaired immune function of GH-transgenic
fish. This hypothesis gets support by the lowered
IGF-I serum levels and GH receptor mRNA in
channel catfish challenged with Edwardsiella ictaluri
(Peterson et al. 2007) and by down-regulated IGF-I
and GH receptor gene expression levels in head
kidney of Enteromyxum leei-infected gilthead sea-
bream while non-infected individuals showed
increased levels (Sitja`-Bobadilla et al. 2008).
Thus, overall GH overexpression does not by
nature imply that all organs are positively stimulated.
Further studies are needed to evaluate the mecha-
nisms involved in this paradoxical phenomenon. Also
the dropped IGF-I serum levels in our GH-transgenic
tilapia (Eppler et al. 2007a) somewhat differ from
findings in transgenic Coho salmon, where IGF-I
serum levels varied between slight enhancement or
reduction (Devlin et al. 2000) and elevation in
smaller individuals (Raven et al. 2008). Similarly, a
positive correlation of body size and plasma IGF-I
concentration had been postulated in wild type Coho
salmon and tilapia (for references see: Eppler et al.
2007a), but our findings in GH-transgenic tilapia
(Eppler et al. 2007a) more support the idea that
growth may be less due to endocrine mechanisms but
to local IGF-I production as has been demonstrated in
transgenic mice where the IGF-I gene was exclu-
sively deleted in liver (Sjo¨gren et al. 1999; Yakar
et al. 1999).
In almost all organs investigated, not only IGF-I
but also IGF-II mRNA was elevated in the GH-
overexpressing tilapia. So far, the role of growth
promotion by IGF-II has been mainly attributed to the
embryonic or developmental phase (Ayson et al.
2002; Radaelli et al. 2008). Thus, our present results
on IGF-II support the hypothesis that life-long
exposure to ubiquitous exogenous GH overexpression
somehow mimicks the embryonic phase (Caelers
et al. 2005). However, an important role of IGF-II in
fish life-long growth is suggested (Reinecke and
Collet 1998) which is especially important for fish
brain with its life-long growth and regeneration
capacity. This hypothesis receives support from the
numerous IGF-II mRNA-expressing neurons in adult
tilapia (Caelers et al. 2003). In GH-overexpressing
tilapia, IGF-II mRNA levels gave a higher response
than IGF-I mRNA which is similar to findings in GH-
injected carp in one study (Tse et al. 2002), while in
another IGF-I mRNA was increased but IGF-II
mRNA remained unaffected (Vong et al. 2003).
Among all organs investigated, transgenic pitui-
tary was the only one to show no change in IGF-I and
IGF-II mRNA. Along with our previous finding that
no exogenous salmon but only endogenous tilapia
GH mRNA was detectable, this underlines the
proposed importance of the local stimulus by the
exogenous transgene (Herna´ndez et al. 1997; Caelers
et al. 2005). Consistent with findings in salmon (Mori
and Devlin 1999), endogenous GH expression was
lowered in the pituitary of our GH-transgenic tilapia
(Caelers et al. 2005). Along with the dropped IGF-I
serum levels (Eppler et al. 2007a) this might indicate
that the endocrine IGF-I feedback mechanism on
pituitary GH regulation, as is well established
throughout evolution (Moriyama et al. 2000; Rei-
necke et al. 2005) is of minor importance at least in
the state of GH redundancy (Eppler et al. 2007a).
To summarize our findings on GH-overexpressing
transgenic tilapia, the local production of IGF-I and
IGF-II in various organs suggests paracrine and auto-
crine roles of both IGFs in organ-specific functions in
fish. We assume that exposure to extrapituitary GH
expression as observed in transgenic fish (Caelers
et al. 2005; Raven et al. 2008) not only increases local
IGF-I expression in liver and skeletal muscle of GH
transgenic tilapia (Eppler et al. 2007a) and coho salmon
(Raven et al. 2008) but in numerous tissues promoting
growth enhancement of the transgenics. Thus, increased
Transgenic Res (2010) 19:231–240 237
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synthesis of IGF-I which occurred in almost all organs
investigated in the present study supports the assump-
tion that paracrine and/or autocrine effects are more
relevant for growth than endocrine. Furthermore, we
show that permanent high expression of GH in the
transgenics not only increases IGF-I but also IGF-II
mRNA in liver and most extrahepatic sites indicating
that IGF-II is also involved in growth regulation. It is
also reasonable that the markedly enhanced expression
of liver IGF-II mRNA, that may in particular mimick an
early developmental stage, is a further reason for
increased growth.
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